IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
0.9985
-0.0515 (-4.90%)
Aug 12, 2026, 4:00 PM EDT - Market closed
IN8bio Market Cap
IN8bio has a market cap or net worth of $9.83 million as of August 12, 2026. Its market cap has decreased by -4.59% in one year.
Market Cap
9.83M
Enterprise Value
-5.95M
1-Year Change
-4.59%
Ranking
Category
Stock Price
$1.00
ChartMarket Cap Chart
Since the IPO on July 30, 2021, IN8bio's market cap has decreased from $187.55M to $9.83M, a decrease of -94.76%. That is a compound annual growth rate of -44.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 9.83M | -56.95% |
| Dec 31, 2025 | 22.84M | 22.52% |
| Dec 31, 2024 | 18.64M | -68.76% |
| Dec 29, 2023 | 59.67M | 5.43% |
| Dec 30, 2022 | 56.60M | -31.25% |
| Dec 31, 2021 | 82.33M | -56.10% |
| Jul 30, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Senti Biosciences Holdings | 11.13M |
| Vistagen Therapeutics | 11.04M |
| Lisata Therapeutics | 11.02M |
| Lunai Bioworks | 10.88M |
| Quoin Pharmaceuticals | 10.75M |
| BioCardia | 10.60M |
| Theriva Biologics | 10.56M |
| CalciMedica | 10.39M |